Covid-19

Aaron Horne is a cardiologist at Johns Hopkins University, Baltimore, MD, USA.

A scientific director at Fondazione MultiMedica Onlus, Milan, Italy. Features in 2 videos on Wondr Medical. Adriana Albini generally speaks on Covid19 Physician Insights, Covid-19, and Influenza.

Works at San Raffaele Hospital, Milan, Lombardia, Italy. Features in 6 videos on Wondr Medical. Alaide Chieffo generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Covid-19.

Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical. Aloke Finn generally speaks on Drug coated balloons (DCB), Primary Percutaneous Coronary Intervention (PPCI), Stents, Drug Eluting Stents (DES), and In-stent Restenosis (ISR).

Andrew Farb is a fda at Food and Drug Administration, Silver Spring, MD, USA.

A nurse at LAU Medical Center-Rizk Hospital , Beirut, Lebanon. Features in 1 video on Wondr Medical. Antoun Yazbek generally speaks on Covid-19 and Covid19 Managing Covid.

Arie Pieter Kappetein works at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.

A director of cardiology at Jaslok Hospital & Research Centre, Mumbai, India. Features in 1 video on Wondr Medical. Ashwin Balachand Mehta generally speaks on Myocardial Perfusion (MPS) and Fractional Flow Reserve (FFR).

Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.

Ben Kenigsberg is a cardiologist at MedStar Washington Hospital Center, Washington, DC, USA.

Bram Zuckerman is a fda at Food and Drug Administration, Silver Spring, MD, USA.

A cardiology nurse at HFR - Hopital Fribourgeois, Bern, Switzerland. Features in 1 video on Wondr Medical. Christophe Augereau generally speaks on Covid-19 and Covid19 Managing Covid.

Cindy L. Grines, MD, MSCAI, FACC, Chief Scientific Officer, Northside Hospital Cardiovascular Institute. Dr. Cindy Grines provides world-renowned knowledge, research and thinking about interventional cardiology – nonsurgical, minimally invasive procedures that rely on small flexible tubes called catheters to treat heart disease. Dr. Grines is the chief scientific officer of Northside Cardiovascular Institute as well as the incoming president of the Society for Cardiovascular Angiography and Interventions. Dr. Grines is a board-certified physician in cardiovascular disease and interventional cardiology. She pioneered primary percutaneous coronary intervention (PCI) for heart attacks. She has a long history of research, publications and clinical trial design with more than 500 publications and numerous book chapters and review chapters. Dr. Grines serves on the editorial boards of several major journals nationally and internationally, and she has co-edited several medical handbooks.

Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.

Works at Ferrarotto Hospital, University of Catania, Catania, Sicilia, Italy. Features in 8 videos on Wondr Medical. Davide Capodanno generally speaks on Cardiovascular Pharmacotherapy, Cardiac Valves, Covid-19, Covid19 Managing Covid, and Dobutamine Stress Echo (DSE).

Works at University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA. Features in 2 videos on Wondr Medical. Dominick Angiolillo generally speaks on Coronary Interventions, Anti-Platelet Drugs , Stable Coronary Artery Disease (CAD), Acute Coronary Syndromes (ACS), and Primary Percutaneous Coronary Intervention (PPCI).

Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.

Fausto J Pinto graduated at Lisbon School of Medicine, Univ Lisbon, did his cardiology training at University Hospital Santa Maria in Lisbon and Stanford University Medical Center, CA, USA, where he was also junior Faculty. He is the Dean of the Faculty of Medicine of the University of Lisbon, Full Professor of Cardiology, Head of Heart and Vascular Department of Santa Maria University Hospital, President of the World Heart Federation (WHF 2021-2), National Coordinator of the Medical Schools Council (2018-2020), President of the Executive Board of the Lisbon Academic Medical Centre, Past-President of the European Society of Cardiology, President of Cardiovascular Center of University of Lisbon (CCUL). He is Consulting Editor and Member of the Editorial Board of several international peer-reviewed journals and honorary member of several international scientific societies and academic centers, including fellow and gold medalist of the European Society of Cardiology (FESC), American College of Cardiology (FACC), American Society of Angiology (FASA), Society for Cardiac Angiography and Interventions (FSCAI) and the American Society of Echocardiography (FASE). He is honorary member of several international scientific societies, academies and Universities, including Full Member of the Portuguese Academy of Medicine and honorary member of Czech Cardiology Society, Colombian Society of Cardiology, Hungarian Society of Cardiology, Societé Française de Cardiologie, Societá Italiana di Ecografia Cardiovasculare, Peruvian Society of Cardiology, Romanian Society of Cardiology, Romanian Academy of Medical Sciences, Russian Society of Cardiology, SBC, Slovakian Society of Cardiology. . Main areas of interest are ischemic heart disease, anticoagulation, heart failure, clinical cardiology and cardiovascular imaging, with particular interest in the use of ultrasound in cardiology and has pioneered the use of intravascular ultrasound in the study of graft atherosclerosis.

Dr Fausto Rigo graduated in Medicine in 1982 and specialized in Cardiovascular Diseases and in Sports Medicine at the University of Padua. From 1985 to 2011, he was a consultant Cardiologist at the Division of Cardiology of Umberto I Hospital of Mestre-Venice. Since 2011, Dr Rigo was Head of Division of Cardiology of dell’Angelo Hospital in Mestre-Venice, Italy. In 2022, Dr Fausto became Head of Center of Cardiology in Villa Salus Hospital/Santa Camillo IRCSS in Venice. He is author of co-author of over 130 papers all registered in PubMed, published and peer reviewed international journals, and over 250 original or inviter oral presentations, at the main scientific events. Impact factor > 500. Author of numerous chapters of books on Imaging in Cardiology. Field of interest: Coronary artery disease, Cardiomyopathy, Heart failure, Expert in Echocardiography/Stress Echocardiography, Magnetic Resonance and CT-Scan, and pioneer in the implementation of coronary flow and reserve assessment with ultrasound.

Gaurav Rao is an interventional cardiologist at Northwell Health, Lake Success, NY, US.

Dr Giora Weisz is the Section-Head and director of the interventional cardiology program at Montefiore Medical Center in New York. He also serves as faculty of the Cardiovascular Research Foundation in New York. Dr Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the Cardiovascular Research Foundation in New York City. Dr Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Dr Weisz has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies for interventional cardiology device positioning and navigation and robotics, as well leading multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr Weisz has published extensively in the most prestigious peer-review medical journals. He is an associate-director of TCT, which is the premier interventional cardiology conference, and is a regular faculty member for the most important international cardiovascular meetings.

Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.

A medical technique manager at Albert Schweitzer Hospital. Features in 1 video on Wondr Medical. Hervé Faltot generally speaks on Covid-19 and Covid19 Managing Covid.

Professor Ian Meredith is the Executive Vice President and Global Chief Medical Officer at Boston Scientific. Previously professor and director of Monash Heart, and executive director of the Monash Cardiovascular Research Centre at Monash University in Melbourne, Australia, Professor Meredith has over 25 years of experience as a clinical and interventional cardiologist. Professor Meredith has been a member of the Board of the National Heart Foundation (Australia) and a member of the Cardiac Society of Australia and New Zealand National Board. In 2019, Professor Meredith received a Doctor Laws honoris causa from Monash University for distinguished and exceptional service to the field of medicine and healthcare.

James Hermiller works at St. Vincent Medical Group, Indianapolis, IN, USA.

Jay mohan is an interventional cardiology fellow at Beaumont Health, Southfield, Michigan, US.

Jeffrey S. Dubin, MD, MBA, serves as Sr. Vice President, Medical Affairs, and Chief Medical Officer for MedStar Washington Hospital Center. Dr. Dubin is responsible for clinical leadership and oversight, along with quality of care, medical education, and research. Dr. Dubin also serves as a Professor of Clinical Emergency Medicine at Georgetown University Medical Center.

A medical imaging nurse at CHC Liège, Liege, Belgium. Features in 1 video on Wondr Medical. John De Schutter generally speaks on Covid-19 and Covid19 Managing Covid.

Jonathan S. Reiner, MD is board-certified in internal medicine, cardiovascular disease, and interventional cardiology. He is also a professor with The George Washington School of Medicine & Health Sciences and the director of Cardiac Catheterization Laboratories. He is a fellow of the American College of Cardiology and maintains membership with the American Heart Association.

Ken Samet is a ceo at MedStar Washington Hospital Center, Washington, DC, USA.

Kim Allan Williams works at Rush University Medical Center, Chicago, IL.

Lowell Satler works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Dr. Reisman received his Medical Degree from Sackler School of Medicine, New York State Program. He did his Internship at Robert Wood Johnson Hospital in New Brunswick. He finished both Residency in Internal Medicine and Cardiology Fellowship at St. Luke’s Roosevelt Hospital in New York. Dr. Reisman completed Interventional Cardiology at University of California San Diego Medical Center in San Diego. Dr. Reisman has a very productive career as exemplified by authorship and co-authorship of over 100 publications. He is a highly regarded practitioner in the field of interventional cardiology and a leader in national education forum. Dr. Reisman serves as Director of Structural Heart Disease at Weill Cornell Medicine

A chief innovation officer at University of Pennsylvania, Philadelphia, PA, USA. Features in 1 video on Wondr Medical. Mark Turco generally speaks on Innovation, Peripheral Vascular Disease (PVD), and Vascular Access (Endovascular).

Works at Duke University Health System, North Carolina, USA. Features in 1 video on Wondr Medical. Mitchell Krucoff generally speaks on Drug Eluting Stents (DES) and Coronary Optical Coherence Tomography (OCT).

An interventional cardiology nurse at Greater Paris University Hospitals, Paris, France. Features in 1 video on Wondr Medical. Monique Lespes generally speaks on Covid-19 and Covid19 Managing Covid.

A nurse at CHUM - University of Montreal Hospital Center, Montreal, Quebec, Canada. Features in 1 video on Wondr Medical. Nathalie Ferlatte generally speaks on Covid-19 and Covid19 Managing Covid.

Works at Papworth Hospital, United Kingdom. Features in 2 videos on Wondr Medical. Nick West generally speaks on Coronary Optical Coherence Tomography (OCT) and General Cardiology.

Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

A cardiopulmonary technician at Santa Maria Hospital, Department of Cardiology, Lisbon, Portugal. Features in 1 video on Wondr Medical. Ricardo Esteves generally speaks on Covid-19 and Covid19 Managing Covid.

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.

Samin Sharma is a consultant cardiologist at Mount Sinai Hospital, New York, USA.

Sara Collins is an interventional cardiologist at Chesapeake Cardiac Care, Annapolis, Maryland.

A cardiologist at UOC Cardiologia, Dipartimento CardioToracoVascolare, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Features in 1 video on Wondr Medical. Sergio Leonardi generally speaks on Pneumonia, Respiratory Distress Syndrome (RDS), Influenza, Covid19 Physician Insights, and Covid-19.

Soma Kalb is a director of clinical science at FDA, Silver Spring, MD, US.

Dr. Steven Bailey is The Chairman of Medicine at LSU Shreveport and the Malcolm Feist Chair of Interventional Cardiology. He also is a Tenured and Emeritus Professor of Medicine and Radiology and previous Chief of the Janey and Dolph Briscoe Jr. Division of Cardiology at the University of Texas Health Science Center in San Antonio, Texas. Dr. Bailey received his medical degree from University of Oregon Health Science Center at Portland and did his medicine residency and cardiology fellowship at Fitzsimmons Army Medical Center in Aurora, Colorado. He is board certified by the American Board of Internal Medicine with subspecialty board certification in both Cardiovascular Disease and Interventional Cardiology. Dr. Bailey's clinical focus is in Adult Congenital/Structural and Valvular heart disease in addition to Coronary Atherosclerotic Disease. His research laboratory is involved in investigating the effects of NOX subtypes in promoting cardiovascular disease. He has translational research in the field of nanotechnologies and nanosensors and holds several patents in these fields. He was the Program Director for Interventional Cardiology at UTHSCSA from 1999 to 2019. Dr. Bailey chaired the UTHSCSA Promotion and Tenure committee. Dr. Bailey is a Past President of the Society for Cardiovascular Angiography and Interventions (SCAI) and is currently the Editor in Chief of Catheterization and Cardiovascular Interventions, which is the official publication of SCAI. He is a Master Fellow of SCAI, Fellow of the American College of Cardiology and a Fellow the American College of Physicians. He is a member of the Association of University Cardiologists, Association of Cardiology Professors as well as the International Andreas Greuntizig Society.

Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”

Tim Henry is an interventional cardiologist at Cedars-Sinai Medical Center, Los Angeles, California, USA.

Wayne Batchelor works at Southern Medical Group, Tallahassee, Fl, USA.

Yuval Binur is an industry at Microalign.